Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 19, Supplement 2, 1 October 2014

Introduction
pp. S1-S1(1)
Authors: Höke, A; Simpson, DM; Freeman, R

Favourites:
ADD
Favourites:
ADD

The regulatory perspective
pp. S15-S16(2)
Author: Simon, LS

Favourites:
ADD

Novel phase II clinical trial design approaches
pp. S16-S18(3)
Author: Katz, N

Favourites:
ADD

Optimizing phase II clinical trials: novel trial designs
pp. S18-S20(3)
Author: Schoenfeld, D

Favourites:
ADD

The placebo response
pp. S20-S22(3)
Author: Farrar, JT

Favourites:
ADD

The role of neurophysiology
pp. S22-S24(3)
Author: Serra, J

Favourites:
ADD

The role of human pain models
pp. S24-S25(2)
Author: Wallace, MS

Favourites:
ADD

The role of imaging
pp. S26-S27(2)
Author: Borsook, D

Favourites:
ADD
Favourites:
ADD

Phenotypic drug screening
pp. S4-S5(2)
Author: Enna, SJ

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more